Skip to main content
Clinical Trials/DRKS00003862
DRKS00003862
Completed
Not Applicable

Monocentre evaluation of morphological and neurocognitive alterations after whole brain radiotherapy using IMRT technique with hippocampal sparing and boost to the metastases - Hipporad-mono

Klinik für Strahlenheilkunde, Freiburg0 sites3 target enrollmentFebruary 18, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C79.3
Sponsor
Klinik für Strahlenheilkunde, Freiburg
Enrollment
3
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2016
End Date
December 31, 2016
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Strahlenheilkunde, Freiburg

Eligibility Criteria

Inclusion Criteria

  • Patients with 4\-8 brain metastases of solid tumors with indication for WBRT
  • Metastases of 5 \- 35mm width
  • RPA classification I and II
  • Written informed consent

Exclusion Criteria

  • Cerebral lymphoma, metastases from germ cell tumors or SLCL
  • RPA classification III
  • lack of MRI tolerance
  • acute neurologic symptoms demanding immediate therapy
  • accompanying diseases with possible cognitive symptoms or white matter change
  • antiepileptic medication: benzodiazepine, barbiturate, topiramat, hydantoine, valproic acid, carbamazepin
  • demetia, depression, diabetes mellitus
  • hypertensive encephalopathy
  • metastases within the hippocampus or with 10mm range

Outcomes

Primary Outcomes

Not specified

Similar Trials